Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Injecting saline to lower bladder puncture risk during retropubic midurethral sling surgery

Official title: Does Retropubic Hydrodissection Decrease Trocar-induced Bladder Perforation Rates During Placement of Retropubic Midurethral Slings? A Randomized Controlled Trial

Run by University of Massachusetts, Worcester · NCT07208682 · Data updated 2026-11-12

This trial tests whether injecting sterile saline into the retropubic space during retropubic midurethral sling surgery can reduce the chance that the trocar will puncture the bladder for adult women having this procedure.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment300 (estimated)
SponsorUniversity of Massachusetts, Worcester
Academic / other
Locations1 site (Worcester, Massachusetts)
StatusRecruiting
StartedApril 3, 2025
Main results expectedApril 2027
Study endsJune 2027
Registry record updatedSeptember 28, 2026
Trial IDNCT07208682 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women fluent in English or Spanish who are scheduled for a retropubic midurethral sling and are able to provide consent and complete questionnaires are ideal candidates.

Probably not a fit

Patients who are pregnant, undergoing concurrent surgery for malignancy, have limited English or Spanish proficiency, or who are having a different type of sling surgery are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled trial at UMass Memorial enrolling adult women scheduled for retropubic midurethral sling surgery who can complete English or Spanish questionnaires. At the preoperative visit participants complete a baseline urinary symptom survey (UDI-6) and on the day of surgery are randomized to receive standardized retropubic hydrodissection (60 mL saline given via a 20-gauge spinal needle, 30 mL on each side) or to no hydrodissection. The primary outcome is the rate of trocar-induced bladder perforation detected intraoperatively; secondary outcomes include postoperative urinary symptoms, pain, estimated blood loss, and voiding trial results. Subjects who are pregnant, have concurrent surgery for malignancy, or cannot complete consent/questionnaires are excluded.

Why it matters

Potential benefit: If successful, this technique could lower the rate of trocar-related bladder perforations and reduce operative time, bleeding, and postoperative urinary complications.

How similar studies have gone: Hydrodissection in this exact application has limited randomized data, and while similar infiltration techniques have been used in pelvic surgery, strong evidence that it reduces trocar-induced bladder perforation is lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* scheduled for retropubic midurethral sling

Exclusion Criteria:

* cognitive or intellectual impairment that would hinder ability to complete questionnaires or be consented
* having concurrent surgery for malignancy

Where it's running

  • University of Massachusetts Memorial Medical Center
    Worcester, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.